使用角膜共聚焦显微镜检测多发性硬化患者的角膜神经丢失和树突状细胞增多
单中心横断面比较研究纳入57例复发缓解型多发性硬化患者和30名年龄匹配健康对照,用角膜共聚焦显微镜定量角膜基底下神经丛和树突状细胞密度,用谱域光学相干断层扫描测量视乳头周围视网膜神经纤维层厚度。多发性硬化患者角膜神经纤维密度、分支密度、纤维长度及视网膜神经纤维层厚度均低于健康对照,树突状细胞密度高于对照,且神经纤维密度和视网膜神经纤维层厚度与神经残疾严重程度呈负相关。作者认为角膜共聚焦显微镜可显示多发性硬化患者的轴索丢失和树突状细胞密度增高,但需进一步纵向研究确认其作为影像生物标志物的用途。
要点
- 多发性硬化患者角膜神经纤维密度较健康对照降低6.78 fibers/mm2(95%CI -11.04至-2.52,P=0.002)。
- 多发性硬化患者树突状细胞密度中位数27.7 cells/mm2,高于健康对照的17.3 cells/mm2(P=0.03),与视神经炎病史无关。
- 神经纤维密度和视网膜神经纤维层厚度与扩展残疾状态量表及多发性硬化严重度量表呈负相关。
核心结论
- 这些数据提示角膜共聚焦显微镜可显示多发性硬化患者的轴索丢失和树突状细胞密度增高。
- 需要额外的纵向研究来确认角膜共聚焦显微镜作为多发性硬化患者影像生物标志物的用途。
研究设计与样本
- 单中心、横断面比较研究,于2016年5月27日至2017年1月30日在一家三级转诊大学医院开展。
- 连续纳入57例复发缓解型多发性硬化患者和30名健康、年龄匹配的对照参与者。
- 用激光扫描活体角膜共聚焦显微镜采集图像定量角膜基底下神经丛指标和树突状细胞密度,用谱域光学相干断层扫描测量视乳头周围视网膜神经纤维层厚度。
主要发现
- 57例多发性硬化患者中42例(74%)为女性,平均(SD)年龄35.4(8.9)岁;30名健康对照中19名(63%)为女性,平均(SD)年龄34.8(10.2)岁。
- 多发性硬化患者较健康对照:角膜神经纤维密度平均(SE)差-6.78(2.14)fibers/mm2(95%CI -11.04至-2.52,P=0.002),神经分支密度平均(SE)差-17.94(5.45)branches/mm2(95%CI -28.77至-7.10,P=0.001),神经纤维长度平均(SE)差-3.03(0.89)mm/mm2(95%CI -4.81至-1.25,P=0.001),视乳头周围视网膜神经纤维层平均厚度平均(SE)差-17.06(3.14)μm(95%CI -23.29至-10.82,P<0.001)。
- 树突状细胞密度中位数(四分位距)在多发性硬化患者为27.7(12.4-66.8)cells/mm2,健康对照为17.3(0-28.2)cells/mm2(P=0.03),与患者视神经炎病史无关。
- 神经纤维密度与扩展残疾状态量表呈负相关(ρ=-0.295;P=0.03),视网膜神经纤维层厚度与扩展残疾状态量表呈负相关(ρ=-0.374;P=0.004)。
- 神经纤维密度与多发性硬化严重度量表呈负相关(R=-0.354;P=0.007),视网膜神经纤维层厚度与多发性硬化严重度量表呈负相关(R=-0.283;P=0.03),其他研究指标未见关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论指出需要额外的纵向研究来确认角膜共聚焦显微镜作为多发性硬化患者影像生物标志物的用途。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Multiple sclerosis (MS) is characterized by demyelination, axonal degeneration, and inflammation. Corneal confocal microscopy has been used to identify axonal degeneration in several peripheral neuropathies. OBJECTIVE: To assess corneal subbasal nerve plexus morphologic features, corneal dendritic cell (DC) density, and peripapillary retinal nerve fiber layer (RNFL) thickness in patients with MS. DESIGN, SETTING, AND PARTICIPANTS: This single-center, cross-sectional comparative study was conducted at a tertiary referral university hospital between May 27, 2016, and January 30, 2017. Fifty-seven consecutive patients with relapsing-remitting MS and 30 healthy, age-matched control participants were enrolled in the study. Corneal subbasal nerve plexus measures and DC density were quantified in images acquired with the laser scanning in vivo corneal confocal microscope, and peripapillary RNFL thickness was measured with spectral-domain optical coherence tomography. MAIN OUTCOMES AND MEASURES: Corneal nerve fiber density, nerve branch density, nerve fiber length, DC density, peripapillary RNFL thickness, and association with the severity of neurologic disability as assessed by the Kurtzke Expanded Disability Status Scale (score range, 0-10; higher scores indicate greater disability) and Multiple Sclerosis Severity Score (score range, 0.01-9.99; higher scores indicate greater severity). RESULTS: Of the 57 participants with MS, 42 (74%) were female and the mean (SD) age was 35.4 (8.9) years; of the 30 healthy controls, 19 (63%) were female and the mean (SD) age was 34.8 (10.2) years. Corneal nerve fiber density (mean [SE] difference, -6.78 [2.14] fibers/mm2; 95% CI, -11.04 to -2.52; P = .002), nerve branch density (mean [SE] difference, -17.94 [5.45] branches/mm2; 95% CI, -28.77 to -7.10; P = .001), nerve fiber length (mean [SE] difference, -3.03 [0.89] mm/mm2; 95% CI, -4.81 to -1.25; P = .001), and the mean peripapillary RNFL thickness (mean [SE] difference, -17.06 [3.14] μm; 95% CI, -23.29 to -10.82; P < .001) were reduced in patients with MS compared with healthy controls. The DC density was increased (median [interquartile range], 27.7 [12.4-66.8] vs 17.3 [0-28.2] cells/mm2; P = .03), independent of a patient's history of optic neuritis. Nerve fiber density and RNFL thickness showed inverse associations with the Expanded Disability Status Scale (ρ = -0.295; P = .03 for nerve fiber density and ρ = -0.374; P = .004 for RNFL thickness) and the Multiple Sclerosis Severity Score (R = -0.354; P = .007 for nerve fiber density and R = -0.283; P = .03 for RNFL thickness), whereas other study measures did not. CONCLUSIONS AND RELEVANCE: These data suggest that corneal confocal microscopy demonstrates axonal loss and increased DC density in patients with MS. Additional longitudinal studies are needed to confirm the use of corneal confocal microscopy as an imaging biomarker in patients with MS.
引用
- Bitirgen G, Akpinar Z, Malik RA, et al. Use of Corneal Confocal Microscopy to Detect Corneal Nerve Loss and Increased Dendritic Cells in Patients With Multiple Sclerosis. JAMA Ophthalmol. 2017. PMID: 28570722. doi:10.1001/jamaophthalmol.2017.1590
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。